Yestar Healthcare Expects Major Profit Surge

Yestar Healthcare Holdings Co Ltd (HK:2393) has released an update.

Yestar Healthcare Holdings Co. Ltd. has announced a forecasted substantial increase in net profit for the interim period of 2024, expected to exceed RMB1,050 million, a stark contrast to the RMB11.6 million reported in the same period of 2023. This growth is largely due to the profit from redeeming senior notes early and a reduction in finance costs. Investors are advised to exercise caution when dealing with the company’s shares until final results are published on August 29, 2024.

For further insights into HK:2393 stock, check out TipRanks’ Stock Analysis page.